Home › Urotheelcelcarcinoom (overgangscelcarcinoom) › Californië › Los Angeles
Urotheelcelcarcinoom (overgangscelcarcinoom) klinische studies in Los Angeles, CA
17 studies voor Urotheelcelcarcinoom (overgangscelcarcinoom) zoeken deelnemers op locaties in en rond Los Angeles (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruterenFase 1
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruterenFase 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruterenFase 1/2
- START Los Angeles, LLC, Los Angeles
- Los Angeles Cancer Network - Century City, Los Angeles
- (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
- en nog 1
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruterenFase 1/2
- University of Southern California, Los Angeles
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruterenFase 3
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
RekruterenFase 2/3
- Research Site, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekruterenFase 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
RekruterenFase 2/3
- Research Site, Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- Los Angeles Cancer Network, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RekruterenFase 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruterenFase 2
- UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
- Kaiser Permanente Los Angeles Medical Offices, Los Angeles
- Kaiser Permanente West Los Angeles Medical Center, Los Angeles
- en nog 6
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Rekruteren
- Urology Group of Southern California, Los Angeles
- Comprehensive Urology, Los Angeles
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RekruterenFase 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RekruterenFase 1/2
- University of Southern California, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
RekruterenFase 1
- University of Southern California, Los Angeles
Urotheelcelcarcinoom (overgangscelcarcinoom) studies in andere steden
- Nashville, TN23 studies
- New York City, NY22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Austin, TX10 studies
- Orange, CA10 studies
Andere studies in Los Angeles
- Niet-kleincellige longkanker87 studies
- Kanker (alle vormen)74 studies
- Borstkanker73 studies
- Prostaatkanker61 studies
- Colorectale kanker59 studies
- Metastatische kanker57 studies
- Eierstokkanker50 studies
- Longkanker45 studies
- Plaveiselcelcarcinoom van hoofd en hals42 studies
- Aldermeesklierkanker35 studies
- Endometriumkanker34 studies
- Melanoom34 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.